 |
||||
 |
Ted K. SchwarzrockTed Schwarzrock, a seasoned executive in the healthcare field, has held numerous positions in publicly traded and privately held companies including "Fortune 500" firms. Mr. Schwarzrock joined Dermatrends, Incorporated, as Chairman, CEO and President in 1999. Dermatrends is a privately held medical research and development company dedicated to the development of proprietary technologies for use in transdermal drug delivery. From 1993 through 1998, Ted was part of the executive management team at SpineTech, Inc., an innovative spinal implant company. His accomplishments at SpineTech included the development of their sales organization and the launch of a revolutionary spinal implant device, driving sales from $2M to $50M in a 15 month timeframe. SpineTech was purchased by Sulzer Medica in January 1998 for $595M with trailing revenues of $50M. From 1991 through 1993, Ted was Vice-President of Ergodyne Corporation, a privately held manufacturer of products designed to reduce the incidence of back injuries. He was previously Vice-President and General Manager of Glassrock Home Health Care, a $175 M division of British Oxygen Corporation. Mr. Schwarzrock has held other senior management positions with: Biomedical Dynamics Corporation; Space Labs, Inc.; Aequitron Medical, Inc.; and Cobe Laboratories, Inc. Ted Schwarzrock holds a Bachelor of Medical Science degree from the University of Minnesota where he also attended the University of Minnesota Medical School. He resides in Minneapolis with his wife Ruth and three children. |
|
||
|
||||
|
Copyright © 2007 US Spine |
||||
